Low-dose IL-2 Plus IFN-alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma.

Clinical trial NCT00502034 · COMPLETED

Trial details

NCT number: NCT00502034
Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 1994-07-01
Primary completion: 2007-04-01
Enrollment: 310

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.